Concepedia

Dale Chappell

DC

Statistics

Publications

7

Citations

897

H-Index

7

Active since

2018

Affiliations

Humanigen (United States)(Current)

Mayo Clinic in Arizona

Mayo Clinic in Florida

Mayo Clinic

WinnMed

Dale Chappell is an author at Humanigen (United States) specializing in immunology, life sciences, and immunotherapy.

Publications per year

2018–2022

7

Publications

7

GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts

Rosalie M. Sterner, Reona Sakemura, Michelle J. Cox et al. · Blood · 2018 · 625 citations · Full text

, , +16

GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia

Zelalem Temesgen, Mariam Assi, Fnu Shweta et al. · Mayo Clinic Proceedings · 2020 · 88 citations · Full text

, , +7

Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial

Zelalem Temesgen, Charles D. Burger, Jason Baker et al. · The Lancet Respiratory Medicine · 2021 · 74 citations · Full text

, , +13

GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activity

Michelle J. Cox, Claudia Manriquez Roman, Erin E. Tapper et al. · Leukemia · 2022 · 38 citations · Full text

, , +16

LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL

Zelalem Temesgen, Charles D. Burger, Jason V. Baker et al. · medRxiv · 2021 · 34 citations · Full text

, , +17

1–5 of 7